Igg-based bispecific anti-cd95 antibodies for the treatment of b cell-derived malignancies and autoimmune diseases
HIGHLIGHTS who: Sebastian Hörner and colleagues from the Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German […]